In addition, FoxP3+Helios- Tregs have been reported to be expanded in NSCLC tumors, and are associated with an increased expression of inflammatory cytokines such as IL-17, and with poor survival [43]. This evidence concerns the gene IL17A and non-small cell lung carcinoma.